Le Melledo JM - Search Results

1

L-Arginine and NOS activity, a complex relationship.

Le Melledo JM, Baker G, Gyenes G, Tsuyuki R, Jurasz P. Le Melledo JM, et al. Psychopharmacology (Berl). 2021 Apr;238(4):1223-1224. doi: 10.1007/s00213-021-05799-7. Epub 2021 Feb 17. Psychopharmacology (Berl). 2021. PMID: 33595692 No abstract available.

2

Neuroactive steroids and anxiety disorders.

Le Mellédo JM, Baker GB. Le Mellédo JM, et al. J Psychiatry Neurosci. 2002 May;27(3):161-5. J Psychiatry Neurosci. 2002. PMID: 12066445 Free PMC article. Review. No abstract available.

3

Paroxetine-induced increase in metabolic end products of nitric oxide.

Lara N, Archer SL, Baker GB, Le Mellédo JM. Lara N, et al. Among authors: le melledo jm. J Clin Psychopharmacol. 2003 Aug;23(4):408-12. doi: 10.1097/01.jcp.0000085416.08426.1d. J Clin Psychopharmacol. 2003. PMID: 12920419 Clinical Trial.

4

Paroxetine-induced increase in metabolic end products of nitric oxide.

Lara N, Archer SL, Baker GB, Le Mellédo JM. Lara N, et al. Among authors: le melledo jm. J Clin Psychopharmacol. 2003 Dec;23(6):641-5. doi: 10.1097/01.jcp.0000085416.08426.1d. J Clin Psychopharmacol. 2003. PMID: 14624192 Clinical Trial.

5

Response to flumazenil in the late luteal phase and follicular phase of the menstrual cycle in healthy control females.

Bell EC, Baker GB, Poag C, Bellavance F, Khudabux J, Le Mellédo JM. Bell EC, et al. Among authors: le melledo jm. Psychopharmacology (Berl). 2004 Mar;172(3):248-54. doi: 10.1007/s00213-003-1660-2. Epub 2004 Jan 8. Psychopharmacology (Berl). 2004. PMID: 14712334 Clinical Trial.

6

Increased cholesterol levels during paroxetine administration in healthy men.

Lara N, Baker GB, Archer SL, Le Mellédo JM. Lara N, et al. Among authors: le melledo jm. J Clin Psychiatry. 2003 Dec;64(12):1455-9. doi: 10.4088/jcp.v64n1209. J Clin Psychiatry. 2003. PMID: 14728107

7

Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder.

Chrapko WE, Jurasz P, Radomski MW, Lara N, Archer SL, Le Mellédo JM. Chrapko WE, et al. Among authors: le melledo jm. Biol Psychiatry. 2004 Jul 15;56(2):129-34. doi: 10.1016/j.biopsych.2004.03.003. Biol Psychiatry. 2004. PMID: 15231445 Clinical Trial.

8

The effects of newer antidepressants on low-density lipoprotein cholesterol levels.

Le Mellédo JM, del Pilar Castillo Abadia M, Newman S, Bailey D, Tsuyuki R, Gyenes G. Le Mellédo JM, et al. J Clin Psychiatry. 2004 Jul;65(7):1017-8; author reply 1018. doi: 10.4088/jcp.v65n0720b. J Clin Psychiatry. 2004. PMID: 15291694 No abstract available.

9

Nitric oxide: a key player in the relation between cardiovascular disease and major depressive disorder?

Le Mellédo JM, Mahil N, Baker GB. Le Mellédo JM, et al. J Psychiatry Neurosci. 2004 Nov;29(6):414-6. J Psychiatry Neurosci. 2004. PMID: 15644982 Free PMC article. No abstract available.

10

Role of progesterone and other neuroactive steroids in anxiety disorders.

Le Mellédo JM, Baker G. Le Mellédo JM, et al. Expert Rev Neurother. 2004 Sep;4(5):851-60. doi: 10.1586/14737175.4.5.851. Expert Rev Neurother. 2004. PMID: 15853511 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters